Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 177

1.

Development of novel monoclonal antibodies with specific binding affinity for denatured human CD26 in formalin-fixed paraffin-embedded and decalcified specimens.

Hatano R, Yamada T, Madokoro H, Otsuka H, Komiya E, Itoh T, Narita Y, Iwata S, Yamazaki H, Matsuoka S, Dang NH, Ohnuma K, Morimoto C.

PLoS One. 2019 Jun 13;14(6):e0218330. doi: 10.1371/journal.pone.0218330. eCollection 2019.

2.

Dipeptidyl peptidase 4 inhibitors as novel agents in improving survival in diabetic patients with colorectal cancer and lung cancer: A Surveillance Epidemiology and Endpoint Research Medicare study.

Bishnoi R, Hong YR, Shah C, Ali A, Skelton WP 4th, Huo J, Dang NH, Dang LH.

Cancer Med. 2019 May 23. doi: 10.1002/cam4.2278. [Epub ahead of print]

3.

Ethanol extract of Polyscias fruticosa leaves suppresses RANKL-mediated osteoclastogenesis in vitro and LPS-induced bone loss in vivo.

Tran PT, Dang NH, Kim O, Van Cuong P, Dat NT, Hwangbo C, Van Minh C, Lee JH.

Phytomedicine. 2019 Jun;59:152908. doi: 10.1016/j.phymed.2019.152908. Epub 2019 Apr 2.

PMID:
30981187
4.

Intratumoral Genetic and Functional Heterogeneity in Pediatric Glioblastoma.

Hoffman M, Gillmor AH, Kunz DJ, Johnston MJ, Nikolic A, Narta K, Zarrei M, King J, Ellestad K, Dang NH, Cavalli FMG, Kushida MM, Coutinho FJ, Zhu Y, Luu B, Ma Y, Mungall AJ, Moore R, Marra MA, Taylor MD, Pugh TJ, Dirks PB, Strother D, Lafay-Cousin L, Resnick AC, Scherer S, Senger DL, Simons BD, Chan JA, Morrissy AS, Gallo M.

Cancer Res. 2019 May 1;79(9):2111-2123. doi: 10.1158/0008-5472.CAN-18-3441. Epub 2019 Mar 15.

PMID:
30877103
5.

Acylated flavonoid glycosides from Barringtonia racemosa.

Van QTT, Vien LT, Hanh TTH, Huong PTT, Cuong NT, Thao NP, Thuan NH, Dang NH, Thanh NV, Cuong NX, Nam NH, Kiem PV, Minh CV.

Nat Prod Res. 2019 Jan 24:1-6. doi: 10.1080/14786419.2018.1560290. [Epub ahead of print]

PMID:
30676065
6.

Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1.

Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH.

Phytomedicine. 2019 Mar 1;55:1-8. doi: 10.1016/j.phymed.2018.10.029. Epub 2018 Oct 25.

PMID:
30668419
7.

A multi-center retrospective analysis of the effect of DPP4 inhibitors on progression-free survival in advanced airway and colorectal cancers.

Ali A, Fuentes A, Skelton WP IV, Wang Y, McGorray S, Shah C, Bishnoi R, Dang LH, Dang NH.

Mol Clin Oncol. 2019 Jan;10(1):118-124. doi: 10.3892/mco.2018.1766. Epub 2018 Nov 13.

8.

Wedtrilosides A and B, two new diterpenoid glycosides from the leaves of Wedelia trilobata (L.) Hitchc. with α-amylase and α-glucosidase inhibitory activities.

Luyen NT, Binh PT, Tham PT, Hung TM, Dang NH, Dat NT, Thao NP.

Bioorg Chem. 2019 Apr;85:319-324. doi: 10.1016/j.bioorg.2019.01.010. Epub 2019 Jan 8.

PMID:
30654223
9.

Degalactotigonin, a Steroidal Glycoside from Solanum nigrum, Induces Apoptosis and Cell Cycle Arrest via Inhibiting the EGFR Signaling Pathways in Pancreatic Cancer Cells.

Tuan Anh HL, Tran PT, Thao DT, Trang DT, Dang NH, Van Cuong P, Kiem PV, Minh CV, Lee JH.

Biomed Res Int. 2018 Dec 16;2018:3120972. doi: 10.1155/2018/3120972. eCollection 2018.

10.

Biological Effects of IL-26 on T Cell-Mediated Skin Inflammation, Including Psoriasis.

Itoh T, Hatano R, Komiya E, Otsuka H, Narita Y, Aune TM, Dang NH, Matsuoka S, Naito H, Tominaga M, Takamori K, Morimoto C, Ohnuma K.

J Invest Dermatol. 2019 Apr;139(4):878-889. doi: 10.1016/j.jid.2018.09.037. Epub 2018 Nov 10.

PMID:
30423328
11.

Hypoglycemic property of triterpenoid saponin PFS isolated from Polyscias fruticosa leaves.

Luyen NT, Dang NH, Binh PTX, Hai NT, Dat NT.

An Acad Bras Cienc. 2018 Jul-Sep;90(3):2881-2886. doi: 10.1590/0001-3765201820170945.

12.

A Small Molecule Targeting the Transmembrane Domain of Death Receptor p75NTR Induces Melanoma Cell Death and Reduces Tumor Growth.

Goh ETH, Lin Z, Ahn BY, Lopes-Rodrigues V, Dang NH, Salim S, Berger B, Dymock B, Senger DL, Ibáñez CF.

Cell Chem Biol. 2018 Dec 20;25(12):1485-1494.e5. doi: 10.1016/j.chembiol.2018.09.007. Epub 2018 Oct 4.

PMID:
30293939
13.

Rheumatic diseases associated with immune checkpoint inhibitors in cancer immunotherapy.

Ohnuma K, Hatano R, Dang NH, Morimoto C.

Mod Rheumatol. 2018 Oct 4:1-32. doi: 10.1080/14397595.2018.1532559. [Epub ahead of print]

PMID:
30285531
14.

Targeting CD26 suppresses proliferation of malignant mesothelioma cell via downmodulation of ubiquitin-specific protease 22.

Okamoto T, Yamazaki H, Hatano R, Yamada T, Kaneko Y, Xu CW, Dang NH, Ohnuma K, Morimoto C.

Biochem Biophys Res Commun. 2018 Oct 2;504(2):491-498. doi: 10.1016/j.bbrc.2018.08.193. Epub 2018 Sep 6.

PMID:
30197002
15.

Anthraquinone and Butenolide Constituents from the Crinoid Capillaster multiradiatus.

Vien LT, Hanh TTH, Huong PTT, Dang NH, Thanh NV, Cuong NX, Nam NH, Thung DC, Kiem PV, Minh CV.

Chem Pharm Bull (Tokyo). 2018 Nov 1;66(11):1023-1026. doi: 10.1248/cpb.c18-00472. Epub 2018 Aug 21.

16.

α-Amylase and α-Glucosidase Inhibitory Activities of Chemical Constituents from Wedelia chinensis (Osbeck.) Merr. Leaves.

Thao NP, Binh PT, Luyen NT, Hung TM, Dang NH, Dat NT.

J Anal Methods Chem. 2018 May 9;2018:2794904. doi: 10.1155/2018/2794904. eCollection 2018.

17.

A novel role for CD26/dipeptidyl peptidase IV as a therapeutic target.

Ohnuma K, Hatano R, Komiya E, Otsuka H, Itoh T, Iwao N, Kaneko Y, Yamada T, Dang NH, Morimoto C.

Front Biosci (Landmark Ed). 2018 Jun 1;23:1754-1779. Review.

PMID:
29772527
18.

Eudesmane and aromadendrane sesquiterpenoids from the Vietnamese soft coral Sinularia erecta.

Huong NT, Ngoc NT, Thanh NV, Dang NH, Cuong NX, Nam NH, Thung DC, The HV, Tuan VS, Kiem PV, Minh CV.

Nat Prod Res. 2018 Aug;32(15):1798-1802. doi: 10.1080/14786419.2017.1402326. Epub 2017 Nov 16.

PMID:
29144177
19.

Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.

Bishnoi R, Bajwa R, Franke AJ, Skelton WP 4th, Wang Y, Patel NM, Slayton WB, Zou F, Dang NH.

Exp Hematol Oncol. 2017 Sep 29;6:26. doi: 10.1186/s40164-017-0087-0. eCollection 2017.

20.

Phase 1 study of inotuzumab ozogamicin combined with R-GDP for the treatment of patients with relapsed/refractory CD22+ B-cell non-Hodgkin lymphoma.

Sangha R, Davies A, Dang NH, Ogura M, MacDonald DA, Ananthakrishnan R, Paccagnella ML, Vandendries E, Boni J, Goh YT.

J Drug Assess. 2017 Aug 16;6(1):10-17. doi: 10.1080/21556660.2017.1315336. eCollection 2017.

21.

Highly Pathogenic Avian Influenza A(H5N1) Viruses at the Animal-Human Interface in Vietnam, 2003-2010.

Creanga A, Hang NLK, Cuong VD, Nguyen HT, Phuong HVM, Thanh LT, Thach NC, Hien PT, Tung N, Jang Y, Balish A, Dang NH, Duong MT, Huong NT, Hoa DN, Tho ND, Klimov A, Kapella BK, Gubareva L, Kile JC, Hien NT, Mai LQ, Davis CT.

J Infect Dis. 2017 Sep 15;216(suppl_4):S529-S538. doi: 10.1093/infdis/jix003.

PMID:
28934457
22.

Flavonoid glycosides from Barringtonia acutangula.

Vien LT, Van QTT, Hanh TTH, Huong PTT, Thuy NTK, Cuong NT, Dang NH, Thanh NV, Cuong NX, Nam NH, Kiem PV, Minh CV.

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3776-3781. doi: 10.1016/j.bmcl.2017.06.066. Epub 2017 Jun 27.

PMID:
28688956
23.

Randomized, phase 3 trial of inotuzumab ozogamicin plus rituximab versus chemotherapy plus rituximab for relapsed/refractory aggressive B-cell non-Hodgkin lymphoma.

Dang NH, Ogura M, Castaigne S, Fayad LE, Jerkeman M, Radford J, Pezzutto A, Bondarenko I, Stewart DA, Shnaidman M, Sullivan S, Vandendries E, Tobinai K, Ramchandren R, Hamlin PA, Giné E, Ando K.

Br J Haematol. 2018 Aug;182(4):583-586. doi: 10.1111/bjh.14820. Epub 2017 Jul 5. No abstract available.

PMID:
28677896
24.

A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.

Komiya E, Hatano R, Otsuka H, Itoh T, Yamazaki H, Yamada T, Dang NH, Tominaga M, Suga Y, Kimura U, Takamori K, Morimoto C, Ohnuma K.

J Dermatol Sci. 2017 Jun;86(3):212-221. doi: 10.1016/j.jdermsci.2017.03.005. Epub 2017 Mar 10.

PMID:
28365081
25.

First-in-human phase 1 of YS110, a monoclonal antibody directed against CD26 in advanced CD26-expressing cancers.

Angevin E, Isambert N, Trillet-Lenoir V, You B, Alexandre J, Zalcman G, Vielh P, Farace F, Valleix F, Podoll T, Kuramochi Y, Miyashita I, Hosono O, Dang NH, Ohnuma K, Yamada T, Kaneko Y, Morimoto C.

Br J Cancer. 2017 Apr 25;116(9):1126-1134. doi: 10.1038/bjc.2017.62. Epub 2017 Mar 14.

26.

ytotoxic Constituents of Mallotus microcarpus.

Thai TH, Hai NT, Hien NT, Ha CTT, Cuong NT, Binh PT, Dang NH, Dat NT.

Nat Prod Commun. 2017 Mar;12(3):407-408.

PMID:
30549897
27.

2-Benzyl-benzofurans from the tubers of Ophiopogon japonicus.

Dang NH, Chung ND, Tuan HM, Van Thanh N, Hiep NT, Lee D, Dat NT.

Chem Cent J. 2017 Feb 6;11:15. doi: 10.1186/s13065-017-0242-z. eCollection 2017.

28.

Cytotoxic Steroids from the Vietnamese Soft Coral Sinularia conferta.

Ngoc NT, Huong PT, Thanh NV, Chi NT, Dang NH, Cuong NX, Nam NH, Thung DC, Kiem PV, Minh CV.

Chem Pharm Bull (Tokyo). 2017 Mar 1;65(3):300-305. doi: 10.1248/cpb.c16-00881. Epub 2017 Jan 12.

29.

Triterpene saponins and megastigmane glucosides from Camellia bugiamapensis.

Huong NT, Vien LT, Hanh TT, Dang NH, Thanh NV, Cuong NX, Nam NH, Truong LH, Ban NK, Kiem PV, Minh CV.

Bioorg Med Chem Lett. 2017 Feb 1;27(3):557-561. doi: 10.1016/j.bmcl.2016.12.020. Epub 2016 Dec 8.

PMID:
28011215
30.

Role of IL-26+CD26+CD4 T Cells in Pulmonary Chronic Graft-Versus-Host Disease and Treatment with Caveolin-1-Ig Fc Conjugate.

Ohnuma K, Hatano R, Itoh T, Iwao N, Dang NH, Morimoto C.

Crit Rev Immunol. 2016;36(3):239-267. doi: 10.1615/CritRevImmunol.2016018772. Review.

PMID:
28008806
31.

A Novel Case of Penile Gangrene in a Patient Treated with Ibrutinib for Chronic Lymphocytic Leukemia.

Skelton WP IV, Akhavan NN, Taylor ZA, Nguyen TC, Hassan H, Townsend TN, Pathak P, Trikha G, Dang NH, Dang LH, Ali A.

Case Rep Oncol Med. 2016;2016:6980198. doi: 10.1155/2016/6980198. Epub 2016 Nov 23.

32.

Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging?

Ali A, Skelton WP IV, Akhavan NN, Nguyen TC, Taylor ZA, Townsend T, Pathak P, Hasija N, Li L, Indrisek J, Watson S, Nixon I, Dang NH, Zlotecki R, Crispen P, Allan R, Abbitt P, Dang LH.

Case Rep Oncol Med. 2016;2016:8125898. Epub 2016 Nov 22.

33.

Cytotoxic Homoisoflavonoids from Ophiopogon japonicus Tubers.

Dang NH, Chung ND, Tuan HM, Hiep NT, Dat NT.

Chem Pharm Bull (Tokyo). 2017 Feb 1;65(2):204-207. doi: 10.1248/cpb.c16-00743. Epub 2016 Dec 3.

34.

Pyrrole Oligoglycosides from the Starfish Acanthaster planci Suppress Lipopolysaccharide-Induced Nitric Oxide Production in RAW264.7 Macrophages.

Vien LT, Hanh TT, Huong PT, Dang NH, Thanh NV, Lyakhova E, Cuong NX, Nam NH, Kiem PV, Kicha A, Minh CV.

Chem Pharm Bull (Tokyo). 2016 Nov 1;64(11):1654-1657. Epub 2016 Sep 7.

35.

Inhibition of VEGF-dependent angiogenesis by the anti-CD82 monoclonal antibody 4F9 through regulation of lipid raft microdomains.

Nomura S, Iwata S, Hatano R, Komiya E, Dang NH, Iwao N, Ohnuma K, Morimoto C.

Biochem Biophys Res Commun. 2016 May 20;474(1):111-117. doi: 10.1016/j.bbrc.2016.04.081. Epub 2016 Apr 19.

PMID:
27103437
36.

Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma.

Lun X, Wells JC, Grinshtein N, King JC, Hao X, Dang NH, Wang X, Aman A, Uehling D, Datti A, Wrana JL, Easaw JC, Luchman A, Weiss S, Cairncross JG, Kaplan DR, Robbins SM, Senger DL.

Clin Cancer Res. 2016 Aug 1;22(15):3860-75. doi: 10.1158/1078-0432.CCR-15-1798. Epub 2016 Mar 22.

37.

Multidimensional Screening Platform for Simultaneously Targeting Oncogenic KRAS and Hypoxia-Inducible Factors Pathways in Colorectal Cancer.

Bousquet MS, Ma JJ, Ratnayake R, Havre PA, Yao J, Dang NH, Paul VJ, Carney TJ, Dang LH, Luesch H.

ACS Chem Biol. 2016 May 20;11(5):1322-31. doi: 10.1021/acschembio.5b00860. Epub 2016 Mar 3.

38.

A New Cytotoxic Gymnomitrane Sesquiterpene from Ganoderma lucidum Fruiting Bodies.

Binh PT, Descoutures D, Dang NH, Nguyen NP, Dat NT.

Nat Prod Commun. 2015 Nov;10(11):1911-2.

PMID:
26749823
39.

A Pilot Study on the Utility of Serum Metabolomics in Neuroblastoma Patients and Xenograft Models.

Beaudry P, Campbell M, Dang NH, Wen J, Blote K, Weljie AM.

Pediatr Blood Cancer. 2016 Feb;63(2):214-20. doi: 10.1002/pbc.25784. Epub 2015 Oct 20.

PMID:
26481088
40.

Sesquiterpenes from the Vietnamese Marine Sponge Dysidea fragilis.

Cue NT, Anh Hle T, Hang DT, Nhiem NX, Dang NH, Nama NH, Yen PH, Thung do C, Thuc VK, Minh CV, Kiema PV.

Nat Prod Commun. 2015 Aug;10(8):1341-2.

PMID:
26434109
41.

Disparities in conditional net survival among non-Hodgkin lymphoma survivors: a population-based analysis.

Migdady Y, Salhab M, Dang NH, Markham MJ, Olszewski AJ.

Leuk Lymphoma. 2016;57(3):676-84. doi: 10.3109/10428194.2015.1102246. Epub 2015 Dec 23.

PMID:
26428541
42.

Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma.

Chihara D, Pro B, Loghavi S, Miranda RN, Medeiros LJ, Fanale MA, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Neelapu SS, Younes A, Fowler NH, Rodriguez MA, Wang M, Kwak LW, McLaughlin P, Dang NH, Oki Y.

Br J Haematol. 2015 Nov;171(4):509-16. doi: 10.1111/bjh.13628. Epub 2015 Aug 10.

PMID:
26260306
43.

Denileukin Diftitox (Ontak) as Maintenance Therapy for Peripheral T-Cell Lymphomas: Three Cases with Sustained Remission.

Fuentes AC, Szwed E, Spears CD, Thaper S, Dang LH, Dang NH.

Case Rep Oncol Med. 2015;2015:123756. doi: 10.1155/2015/123756. Epub 2015 Jul 9.

44.

New flavonoid and pentacyclic triterpene from Sesamum indicum leaves.

Dat NT, Dang NH, Thanh le N.

Nat Prod Res. 2016;30(3):311-5. doi: 10.1080/14786419.2015.1057730. Epub 2015 Jul 16.

PMID:
26181100
45.

Glioma invasion mediated by the p75 neurotrophin receptor (p75(NTR)/CD271) requires regulated interaction with PDLIM1.

Ahn BY, Saldanha-Gama RF, Rahn JJ, Hao X, Zhang J, Dang NH, Alshehri M, Robbins SM, Senger DL.

Oncogene. 2016 Mar 17;35(11):1411-22. doi: 10.1038/onc.2015.199. Epub 2015 Jun 29.

46.

The role of Cas-L/NEDD9 as a regulator of collagen-induced arthritis in a murine model.

Katayose T, Iwata S, Oyaizu N, Hosono O, Yamada T, Dang NH, Hatano R, Tanaka H, Ohnuma K, Morimoto C.

Biochem Biophys Res Commun. 2015 May 15;460(4):1069-75. doi: 10.1016/j.bbrc.2015.03.156. Epub 2015 Apr 3.

PMID:
25847598
47.

Modulation of immunological responses and amelioration of collagen-induced arthritis by the novel roxithromycin derivative 5-I.

Otsuki N, Iwata S, Yamada T, Hosono O, Dang NH, Hatano R, Ohnuma K, Morimoto C.

Mod Rheumatol. 2015 Jul;25(4):562-70. doi: 10.3109/14397595.2014.983262. Epub 2015 Mar 24.

PMID:
25800509
48.

New primary malignancy masquerading as metastatic prostate adenocarcinoma.

Szwed EA, Sliesoraitis S, Nguyen TC, Nguyen MN, Moreb JS, Zlotecki RA, Crispen PL, Dang NH, Dang LH.

Case Rep Oncol Med. 2015;2015:358572. doi: 10.1155/2015/358572. Epub 2015 Feb 19.

49.

Regulation of pulmonary graft-versus-host disease by IL-26+CD26+CD4 T lymphocytes.

Ohnuma K, Hatano R, Aune TM, Otsuka H, Iwata S, Dang NH, Yamada T, Morimoto C.

J Immunol. 2015 Apr 15;194(8):3697-712. doi: 10.4049/jimmunol.1402785. Epub 2015 Mar 18.

50.

CD26-mediated induction of EGR2 and IL-10 as potential regulatory mechanism for CD26 costimulatory pathway.

Hatano R, Ohnuma K, Otsuka H, Komiya E, Taki I, Iwata S, Dang NH, Okumura K, Morimoto C.

J Immunol. 2015 Feb 1;194(3):960-72. doi: 10.4049/jimmunol.1402143. Epub 2014 Dec 29.

Supplemental Content

Support Center